La gripe en adultos en américa latina, situación actual y tendencias futuras: Una declaración de consenso

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 31, Issue 6, 2012, Pages 506-512

  Bonvehí, Pablo E ^a   Istúriz, Raúl E ^b   Labarca, Jaime A ^c   Rüttimann, Ricardo W ^d   Vidal, Edison I ^e   Vilar Compte, Diana ^f  

^a CEMIC   (Argentina)

^b Centro Medico Docente La Trinidad   (Venezuela)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d Fighting Infectious Diseases in Emerging Countries (FIDEC)   (United States)

^e SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^f INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Adult; Consensus development conferences as topic; Human; Immunization; Influenza; Influenza vaccines; Latin America

Indexed keywords

DISEASE PREVALENCE; HEALTH RISK; IMMUNIZATION; INFECTIOUS DISEASE; INFLUENZA; MORBIDITY; MORTALITY;

LATIN AMERICA;

EID: 84866043466     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/s1020-49892012000600009     Document Type: Review

References (57)

1. World Health Organization. Influenza Fact Sheet No 211 [Internet]. Geneva: WHO; 2003. Available from: Http://www.who.int/media centre/factsheets/ 2003/fs211/en/Accessed 20 May 2008.
2. Centers for Disease Control and Prevention (US). Estimates of deaths associated with seasonal influenza-United States, 1976-2007. MMWR Morb Mortal Wkly Rep. 2010;59(33):1057-62.
3. Isturiz RE, Luna CM, Ramirez J. Clinical and economic burden of pneumonia among adults in Latin America. Int J Infect Dis. 2010;14(10):e852-6.
4. Kuri-Morales P, Galván F, Cravioto P, Zárraga Rosas LA, Tapia-Conyer R. Mortalidad en México por influenza y neumonía (1990-2005). Salud Publica Mex. 2006;48(5):379-84. (Pubitemid 44624719)
5. World Health Organization. Influenza vaccines. WHO position paper. Wkly Epidemiol Rec. 2005;80(33):279-87. Available from: Http://www.who.int/ immunization/wer 8033influenza-August2005-position-paper. pdf Accessed 5 January 2012.
6. Ropero-Alvarez AM, Kurtis HJ, Danovaro-Holliday MC, Ruiz-Matus C, Andrus JK. Expansion of seasonal influenza vaccination in the Americas. BMC Public Health. 2009;9(1):361.
7. Wenzel RP, Edmond MB. Preparing for 2009 H1N1 influenza. N Engl J Med. 2009;361(20):1991-3.
8. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: Implications for control in health care settings. Clin Infect Dis. 2003;37(8):1094-101. (Pubitemid 37323665)
9. Racaniello V. Comments on "Influenza A/Mexico/2009 (H1N1) virulence and transmission." 2009 May 12. In: Racaniello V. Virology blog: About viruses and viral disease [Internet]. New York: Vincent Racaniello; c2004-2012. Available from: Http://www.virology. ws/2009/05/12/influenza-h1n1- virulencetransmission Accessed 15 September 2010.
10. Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med. 2010;362(1):45-55.
11. Moura FE. Influenza in the tropics. Curr Opin Infect Dis. 2010;23(5):415-20.
12. Alonso WJ, Viboud C, Simonsen L, Hirano EW, Daufenbach LZ, Miller MA. Seasonality of influenza in Brazil: A traveling wave from the Amazon to the subtropics. Am J Epidemiol. 2007;165(12):1434-42. (Pubitemid 47234305)
13. Finkelman BS, Viboud C, Koelle K, Ferrari MJ, Bharti N, Grenfell BT. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: Viral coexistence and latitudinal gradients. PLoS One. 2007;2(12):e1296.
14. Ramírez AP, Mendoza AR, Montoya JM, Cótes K, López JD, Herrera D, et al. Mortalidad asociada con las temporadas de mayor circulación de los virus de la influenza en Bogotá, Colombia, 1997-2005. Rev Panam Salud Publica. 2009;26(5):435-9.
15. Echavarría M, Querci M, Marcone D, Videla C, Martínez A, Bonvehi P, et al. Pandemic (H1N1) 2009 cases, Buenos Aires, Argentina. Emerg Infect Dis. 2010;16(2):311-3.
16. Richard SA, Viboud C, Miller MA. Evaluation of Southern Hemisphere influenza vaccine recommendations. Vaccine. 2010;28(15):2693-9.
17. Wang R, Taubenberger JK. Methods for molecular surveillance of influenza. Expert Rev Anti Infect Ther. 2010;8(5):517-27.
18. Nguyen JT, Hoopes JD, Smee DF, Prichard MN, Driebe EM, Engelthaler DM, et al. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother. 2009;53(10): 4115-26.
19. Mensua A, Mounier-Jack S, Coker R. Pandemic influenza preparedness in Latin America: Analysis of national strategic plans. Health Policy Plan. 2009;24(4):253-60. Available from: Http://heapol.oxfordjournals.org/content/24/ 4/253 Accessed 5 January 2012.
20. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8): 1003-32.
21. Cox NJ, Subbarao K. Influenza. Lancet. 1999;354(9186):1277-82. (Pubitemid 29469365)
22. Gross PA, Russo C, Dran S, Cataruozolo P, Munk G, Lancey SC. Time to earliest peak serum antibody response to influenza vaccine in the elderly. Clin Diagn Lab Immunol. 1997;4(4):491-2. (Pubitemid 27321787)
23. Cate TR, Couch RB, Parker D, Baxter B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines-1978. Rev Infect Dis. 1983;5(4):737-47.
24. Lerman SJ, Wright PF, Patil KD. Antibody decline in children following A/New Jersey/76 influenza virus immunization. J Pediatr. 1980;96(2):271-4. (Pubitemid 10129416)
25. de Mello WA, de Paiva TM, Ishida MA, Benega MA, Dos Santos MC, Viboud C, et al. The dilemma of influenza vaccine recommendations when applied to the tropics: The Brazilian case examined under alternative scenarios. PLoS One. 2009;4(4):e5095.
26. Reisinger KS, Block SL, Izu A, Groth N, Holmes SJ. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: Comparison of safety, reactogenicity, and immunogenicity. J Infect Dis. 2009;200(6):849-57.
27. Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database. Vaccine. 2009;27(49):6959-65.
28. Schultze V, D'Agosto V, Wack A, Novicki D, Zorn J, Hennig R. Safety of MF59 adjuvant. Vaccine. 2008;26(26):3209-22.
29. European Medicines Agency. Pandemrix: Influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted) A/California/7/2009 (H1N1)v like strain (x-179a) [Internet]. London: EMA; 2009 [updated 25 Nov 2011]. Available from: Http://www.ema. europa.eu/ema/index.jsp?curl=pages/medi cines/human/medicines/ 000832/human-med-000965.jsp&mid=WC0b01ac058001d124 Accessed 25 November 2012.
30. Lambert PH, Laurent PE. Intradermal vaccine delivery: Will new delivery systems transform vaccine administration? Vaccine. 2008;26(26):3197-208.
31. Van Damme P, Arnou R, Kafeja F, Fiquet A, Richard P, Thomas S, et al. Evaluation of noninferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: A randomised comparative study. BMC Infect Dis. 2010;10(1):134.
32. Gurfikel EP, de la Fuente RL. Two-year follow-up of the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Registry. Tex Heart Inst J. 2004;31(1):28-32. (Pubitemid 38366812)
33. Stamboulian D, Bonvehí PE, Nacinovich FM, Rüttimann RW. Immunization against influenza in the elderly: The Argentinian experience, 1993-1997. Vaccine. 1999;17 Suppl 1:S53-6. (Pubitemid 29366934)
34. Mannino S, Villa M, Weiss N, Apolone G, Rothman KJ. Effectiveness of influenza vaccination with Fluad versus a sub-unit influenza vaccine. Abstracts of the 43rd Annual Meeting of the Society for Epidemiologic Research, 23-26 June, Anaheim, California. Am J Epidemiol. 2010;171(Suppl 11):S157.
35. Steinhoff MC, Omer SB, Roy E, Arifeen SE, Raqib R, Altaye M, et al. Influenza immunization in pregnancy-antibody responses in mothers and infants. New Engl J Med. 2010;362(17):1644-6.
36. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, et al. Effectiveness of maternal influenza immunization in mothers and infants. New Engl J Med. 2008;359(15):1555-64.
37. Erratum in: New Engl J Med. 2009;360(6):648. Breiman, Robert E [corrected to Breiman, Robert F].
38. Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJ, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: A randomized trial. JAMA. 2010;303(10):943-50.
39. Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis. 2010;202(11):1626-33.
40. Lewin EB. A paradigm for the control of influenza. J Infect Dis. 2010;202(11):1619-22.
41. Reichert TA. The Japanese program of vaccination of schoolchildren against influenza: Implications for control of the disease. Semin Pediatr Infect Dis. 2002;13(2):104-11. (Pubitemid 34492551)
42. Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand MC, Enouf V, et al. Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis. 2009;48(1):48-56.
43. de Lataillade C, Auvergne S, Delannoy I. 2005 and 2006 seasonal influenza vaccination coverage rates in 10 countries in Africa, Asia Pacific, Europe, Latin America and the Middle East. J Public Health Policy. 2009;30(1):83-101.
44. Stamboulian D, Bonvehí PE, Nacinovich FM, Cox N. Influenza. Infect Dis Clin North Am. 2000;14(1):141-66.
45. World Health Organization. Pandemic influenza preparedness and response: A WHO guidance document. Geneva: WHO Global Influenza Programme; 2009. Available from: Http://whqlibdoc.who.int/publications/2009/9789241547680-eng.pdf Accessed 8 November 2010.
46. Halder N, Kelso JK, Milne GJ. Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic. BMC Public Health. 2010;10(1):168.
47. Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM. Managing and reducing uncertainty in an emerging influenza pandemic. New Engl J Med. 2009;361(2):112-5.
48. Buss P, Koplan JP, Dusenbury C, Binder S, Rosenberg F. Los institutos nacionales de salud pública: Un enfoque coordinado e integral contra la influenza A H1N1 y otras amenazas a la salud pública. Rev Panam Salud Publica. 2009;26(2):184-8.
49. Mujica OJ, Olivia O, dos Santos T, Ehrenberg JP. Planificación de la preparación para la influenza pandémica: Esfuerzos regionales. Rev Panam Salud Publica. 2008;23(6);428-34.
50. Jefferson T, Del Mar C, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: Systematic review. BMJ. 2009;339:b3675. doi: 10.1136/bmj. b3675.
51. Rabagliati R, Labarca J, Siri L, Perez CM, Ferrés M. Rates of hospital-acquired influenza due to the pandemic H1N1 virus in 2009, compared with seasonal influenza. Infect Control Hosp Epidemiol. 2011;32(2):198-200.
52. Ministerio de Salud (AR). Lineamientos técnicos. Campaña Nacional de Vacunación Antigripal: Argentina 2011. Buenos Aires: MS; 2011. Available from: Http://www.msal.gov.ar/gripe2011/5-equipos/info-equipos/ lin eamientos-tecnicos-gripe-2011.pdf Accessed 10 January 2012.
53. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A. Antivirals for influenza in healthy adults: Systematic review. Lancet. 2006;367(9507):303-13. (Pubitemid 43151463)
54. Erratum in: Lancet. 2006;367(9528):2060.
55. Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. New Engl J Med. 1999;341(18):1336-43. (Pubitemid 29503572)
56. Monto AS, Robinson DP, Herlocher ML, Hinson JM Jr, Elliot MJ, Crisp A. Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial. JAMA. 1999;282(1):31-5. (Pubitemid 29318929)
57. Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: A randomized controlled trial. JAMA. 2001;285(6):748-54. (Pubitemid 32167233)